Quest Diagnostics DGX
$258.28 −$0.81 (-0.31%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $259.00 +0.28%
Open$262.00
Prev close$259.09
Day range$257.56 – $262.96
Volume1.37M
Market cap$28.42B
P/E (TTM)25.7
Dividend yield1.31%
DGX Stock News
Headlines matching Quest Diagnostics or the DGX ticker, most recent first.
- UBS Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $245 Positive
- Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $250
- Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Maintains Target Price $260
- Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $260 Positive
- Quest Diagnostics(DGX.US) Officer Sells US$5.51 Million in Common Stock
- Morgan Stanley Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260
- Mizuho Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260
- Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Maintains Target Price $250
- Argus Research Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $260 Positive
- J.P. Morgan Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $250 Positive
- A Quick Look at Today's Ratings for Quest Diagnostics(DGX.US), With a Forecast Between $232 to $265
- A Quick Look at Today's Ratings for Quest Diagnostics(DGX.US), With a Forecast Between $232 to $260
- Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $230
- BofA Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $245 Positive
- Baird Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $236 Positive
No comments yet — be the first to weigh in on DGX.
Sign in to join the discussion.